Literature DB >> 25137474

Retraction: Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.

.   

Abstract

Entities:  

Year:  2014        PMID： 25137474     DOI： 10.1038/ni0914-894a

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  1 in total

1.  Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.

Authors:  Agnès Doreau; Alexandre Belot; Jérémy Bastid; Benjamin Riche; Marie-Claude Trescol-Biemont; Bruno Ranchin; Nicole Fabien; Pierre Cochat; Claire Pouteil-Noble; Pierre Trolliet; Isabelle Durieu; Jacques Tebib; Berhouz Kassai; Stéphane Ansieau; Alain Puisieux; Jean-François Eliaou; Nathalie Bonnefoy-Bérard
Journal:  Nat Immunol       Date:  2009-05-31       Impact factor: 25.606
  1 in total
  1 in total

1.  IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: Evidence for a dual role.

Authors:  Warren Raymond; Gro Ostli-Eilertsen; Sheynae Griffiths; Johannes Nossent
Journal:  Eur J Rheumatol       Date:  2017-03-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.